feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering",https://benzinga.com/news/earnings/21/08/22440430/the-daily-biotech-pulse-fda-rejects-fibrogens-anemia-drug-crinetics-gains-on-positive-readout-biocr,https://j.mp/3xDWM9p
